Single Pass Albumin Dialysis in Patients With Cirrhosis
Phase 1
Completed
- Conditions
- CirrhosisEncephalopathyAcute on Chronic Hepatic FailureHepatorenal Syndrome
- Interventions
- Device: Single pass albumin dialysis
- Registration Number
- NCT00764049
- Lead Sponsor
- Assistance Publique - H么pitaux de Paris
- Brief Summary
The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.
- Detailed Description
Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
- Minimum age of 18 years
- Written consent after information of the patient or, in case of inability, by a parent or a close if he is present.
- Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons)
Read More
Exclusion Criteria
- Participation to an other study in the 4 weeks before
- Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1: Single pass albumin dialysis Single pass albumin dialysis Patients entered in the pilot study.
- Primary Outcome Measures
Name Time Method Effects on clinical and biochemical variables 3 months follow-up
- Secondary Outcome Measures
Name Time Method Safety 3 months
Trial Locations
- Locations (1)
H么pital Beaujon
馃嚝馃嚪Clichy, France